Lo: How Should Vaccines Be Financed?
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
By
Technology and training are not enough to safeguard companies against cybersecurity attacks. Here’s how to infuse safe behavior into corporate culture.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
Fellowship applications open on May 3, 2021 for entrepreneurs working and living in Ethiopia, Ghana, Nigeria, Kenya, Rwanda, Senegal, and Uganda.
By
Integrating robots into a manufacturing system is often prohibitively expensive. A new approach could change that.
By
Maria Ressa built a successful media startup — and exposed human rights issues — while fighting disinformation and attacks from the Philippine government.
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
By
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.